merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 cap takes effect before the 2026 negotiated prices (in the year prior).</answer>
<question_number>2</question_number>
<answer>Project 2025 calls for repealing the program, implying that an expanding list of negotiated drugs could be undone under a future Republican administration.</answer>
<question_number>3</question_number>
<answer>Harris helped pass the negotiation legislation (cast the tiebreaking vote) and is highlighting drug‑price reforms and “taking on Big Pharma” as a top priority in her campaign.</answer>
<question_number>4</question_number>
<answer>N/A</answer>
<question_number>5</question_number>
<answer>$1,716</answer>
<question_number>6</question_number>
<answer>N/A</answer>
<question_number>7</question_number>
<answer>Januvia</answer>
<question_number>8</question_number>
<answer>approximately 92.5 %</answer>
<question_number>9</question_number>
<answer>$19</answer>
<question_number>10</question_number>
<answer>N/A</answer>